PTGX icon

Protagonist Therapeutics
PTGX

Overview Fund Activity

185 hedge funds and large institutions have $1.73B invested in Protagonist Therapeutics in 2024 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 61 increasing their positions, 57 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
185
Holders Change
+29
Holders Change %
+18.59%
% of All Funds
2.68%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
49
Increased
61
Reduced
57
Closed
20
Calls
$1.14M
Puts
$6.85M
Net Calls
-$5.71M
Net Calls Change
-$17.8M

Top Buyers

1
CAC
1
Cowen and Company
New York
$45.1M
2
FFM
2
Fairmount Funds Management
Pennsylvania
$27M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$64.2M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$28.3M
5
WP
5
Woodline Partners
California
$18.4M

Top Sellers

1
BI
1
BVF Inc
California
$109M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$34.7M
3
KCM
3
Kynam Capital Management
New Jersey
$33.1M
4
Morgan Stanley
4
Morgan Stanley
New York
$54.4M
5
SC
5
Stempoint Capital
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
QL
201
Quarry LP
New York
– -$17.2K -750 Closed
Northwestern Mutual Wealth Management
202
Northwestern Mutual Wealth Management
Wisconsin
– -$2.29K -100 Closed
PNC Financial Services Group
203
PNC Financial Services Group
Pennsylvania
– -$115 -5 Closed
GI
204
Gradient Investments
Minnesota
– -$23 -1 Closed
5 6 7 8
9